Given the known function(s) of IRF5 in regulating proinflammatory cytokine/chemokine expression [3,4,6], combined with its cellular expression in breast tissue and high expression in infiltrating leukocytes in the tumor stroma of IDC patients (Additional file 5), suggest that IRF5 may play an important role in breast cancer invasion. Here, IRF5 is linked to breast carcinoma.